How immersive technology could drive the future of healthcare

How immersive technology could drive the future of healthcare

Jeffrey Tan
11/01/19, 11:39 am

SINGAPORE (Jan 11): Immersive technology is ­increasingly being deployed in various fields other than electronic games and entertainment. 

Take medicine for example, where Singapore start-up BetaSight is using virtual reality (VR) headsets to make the diagnosis of glaucoma easier. 

Glaucoma is an eye condition in which the optic nerve is damaged as a result of ­abnormally high pressure in the eye. If the damage continues, it can cause permanent vision loss. 

BetaSight’s solution tracks a patient’s eye movements in response to pop-up virtual objects generated by the VR headset.

According to BetaSight’s founders, the current process of diagnosis can be taxing and lead to skewed results. One of the start-up’s investors even had to take the test twice, and was charged double the price.

With BetaSight’s VR headsets, patients do not have to sit still or press any buttons – unlike the traditional procedure which uses a visual field analyser.

Instead, they only have to put on the VR headset and track the virtual objects with their eyes, which is more intuitive than pressing a button. A person who has glaucoma will have a diminished field of vision and not be able to spot all of the virtual objects.

The VR headset is portable and considerably less bulky than the visual field analyser equipment in use today.

In our latest issue of The Edge Singapore (Issue 864, week of Jan 14), Betasight’s founders Martin Sawtell and Corey Manders tell us how they first came up with the idea of using VR technology to diagnose glaucoma, as well as discuss the enormous potential of VR and AR technologies.

Login to read the full story, BetaSight develops better vision test using virtual reality headsets, or click here to subscribe.

DBS kept at 'buy' with still more upside expected ahead: RHB

SINGAPORE (Jan 21): RHB Research is maintaining its “buy” call on DBS Group Holdings with an unchanged target price of $29.80. This comes on the back of expectations of still more upside ahead, led by widening net interest margin (NIM). Analyst Leng Seng Choon notes that the 3-month SIBOR has been on a rising trend. It currently stands at 1.89%, after hitting an average of 1.73% in 4Q18 – some 0.1 percentage point higher than the preceding quarter. While he explains that there is some lag effect from the SIBOR rise to filter through to NIM widening, Leng believes DBS’ 4Q18 NIM....

Temasek ramps up pressure over Standard Chartered turnround: FT

SINGAPORE (Jan 21): Standard Chartered’s largest investor Temasek has grown frustrated with the slow pace of chief executive Bill Winters’ turnround, according to a report by The Financial Times of UK, and is stepping up pressure on the UK-listed bank ahead of his pivotal strategy update in February. The Singapore state investment company, which owns about 16% of StanChart, was reported by FT to be asking for more frequent and detailed briefings from top executives and even floated the prospect of taking a board seat in a meeting last year, two people with knowledge of the discussion to....

Ascendas-Singbridge properties to house public EV charging network with help from SP Group

SINGAPORE (Jan 21): Ascendas-Singbridge Group is appointed as Singapore Power (SP) Group’s first major location partner in its plans to build “Singapore’s largest and fasted public EV charging network” with 1,000 charging points island-wide by 2020. Under the partnership, 24 charging points were installed in six buildings owned by Ascendas-Singbridge – Hyflux Innovation Centre at  80 Bendemeer Road, Corporation Place, Techlink, Techplace I, The Capricorn and The Kendall – with operations commencing in phases since Dec 2018.   Main image: SP Group CEO Wong Kim Yin (l....